Simultaneous Runs of the Bayer VERSANT HIV-1 Version 3.0 and HCV bDNA Version 3.0 Quantitative Assays on the System 340 Platform Provide Reliable Quantitation and Improved Work Flow

Branched DNA (bDNA) assays to quantify human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) consist of three distinct steps, including sample processing, hybridization, and detection, and utilize the System 340 platform for plate incubation and washing. Sample processing differs:...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Elbeik, Tarek, Markowitz, Norman, Nassos, Patricia, Kumar, Uday, Beringer, Scott, Haller, Barbara, Ng, Valerie
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2004
Matèries:
Virology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC446273/
https://ncbi.nlm.nih.gov/pubmed/15243070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.42.7.3120-3127.2004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars